Home  |  Contact

Cellosaurus SK-N-ASrOXALI4000 (CVCL_RR29)

Cell line name SK-N-ASrOXALI4000
Accession CVCL_RR29
Resource Identification Initiative To cite this cell line use: SK-N-ASrOXALI4000 (RRID:CVCL_RR29)
Comments Part of: Resistant Cancer Cell Line (RCCL) collection.
Selected for resistance to: ChEBI; CHEBI:31941; Oxaliplatin (Elotaxin; L-OHP).
Disease Neuroblastoma (NCIt: C3270)
Derived from metastatic site: Bone marrow.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_1700 (SK-N-AS)
Sex of cell Female
Age at sampling 6Y
Category Cancer cell line
STR profile Source(s): PubMed=28192521

Markers:
AmelogeninX
CSF1PO10,12
D13S3179
D16S53914
D5S81811,12
D7S82011,13
TH019.3
TPOX11,12
vWA16,17
Web pages http://www.wass-michaelislab.org/rccl.php
Publications

PubMed=28192521; DOI=10.1371/journal.pone.0172140
Saintas E., Abrahams L., Ahmad G.T., Ajakaiye A.M., Alhumaidi A.S.H.A.M., Ashmore-Harris C., Clark I., Dura U.K., Fixmer C.N., Ike-Morris C., Mato Prado M., Mccullough D., Mishra S., Scholer K.M., Timur H., Williamson M.D., Alatsatianos M., Bahsoun B., Blackburn E., Hogwood C.E., Lithgow P.E., Rowe M., Yiangou L., Rothweiler F., Cinatl J. Jr., Zehner R., Baines A.J., Garrett M.D., Gourlay C.W., Griffin D.K., Gullick W.J., Hargreaves E., Howard M.J., Lloyd D.R., Rossman J.S., Smales C.M., Tsaousis A.D., von der Haar T., Wass M.N., Michaelis M.
Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-AS.
PLoS ONE 12:E0172140-E0172140(2017)

Cross-references
Other Wikidata; Q54954430